163 related articles for article (PubMed ID: 32304873)
1. Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.
Maakaron JE; Liscynesky C; Boghdadly ZE; Huang Y; Agyeman A; Brammer J; Penza S; Efebera Y; Benson D; Rosko A; William B; Jaglowski SM
Biol Blood Marrow Transplant; 2020 Aug; 26(8):e198-e201. PubMed ID: 32304873
[TBL] [Abstract][Full Text] [Related]
2. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140
[TBL] [Abstract][Full Text] [Related]
5. The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Guare EG; Hale CM; Sivik J; Lehman E; Inoue Y; Rakszawski K; Songdej N; Nickolich M; Zheng H; Naik S; Claxton D; Rybka W; Hohl R; Mineishi S; Minagawa K; Paules CI
Transpl Infect Dis; 2024 Apr; 26(2):e14241. PubMed ID: 38269469
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
Zavrelova A; Paterova P; Gabalec F; Zak P; Radocha J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):161-165. PubMed ID: 30198521
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation.
Simondsen KA; Reed MP; Mably MS; Zhang Y; Longo WL
J Oncol Pharm Pract; 2013 Dec; 19(4):291-7. PubMed ID: 23184539
[TBL] [Abstract][Full Text] [Related]
8. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis.
Owattanapanich W; Suphadirekkul K; Kunacheewa C; Ungprasert P; Prayongratana K
BMC Cancer; 2018 Nov; 18(1):1126. PubMed ID: 30445930
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
Gardner JC; Courter JD; Dandoy CE; Davies SM; Teusink-Cross A
Transplant Cell Ther; 2022 Mar; 28(3):167.e1-167.e5. PubMed ID: 34875405
[TBL] [Abstract][Full Text] [Related]
11. Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single-centre, retrospective review in the Australian setting.
Tan XN; Yew CY; Ragg SJ; Harrup RA; Johnston AM
Intern Med J; 2022 Jul; 52(7):1242-1250. PubMed ID: 33949777
[TBL] [Abstract][Full Text] [Related]
12. Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation.
Clemmons AB; Gandhi AS; Albrecht B; Jacobson S; Pantin J
J Oncol Pharm Pract; 2019 Mar; 25(2):326-332. PubMed ID: 29059026
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
[TBL] [Abstract][Full Text] [Related]
14. Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.
Clerici D; Galli L; Greco R; Lugli AP; Erbella F; Ripa M; Tassan Din C; Nitti R; Giglio F; Mastaglio S; Lorentino F; Xue E; Farina F; Liberatore C; Poli A; Carletti S; Lupo Stanghellini MT; Carrabba MG; Assanelli AA; Ruggeri A; Bernardi M; Corti C; Peccatori J; Mancini N; Scarpellini P; Ciceri F; Castagna A; Oltolini C
Blood Adv; 2023 May; 7(9):1621-1634. PubMed ID: 36409602
[TBL] [Abstract][Full Text] [Related]
15. Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Satlin MJ; Chen L; Douglass C; Hovan M; Davidson E; Soave R; La Spina M; Gomez-Arteaga A; van Besien K; Mayer S; Phillips A; Hsu JM; Malherbe R; Small CB; Jenkins SG; Westblade LF; Kreiswirth BN; Walsh TJ
Clin Infect Dis; 2021 Oct; 73(7):1257-1265. PubMed ID: 33956965
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster prophylaxis with low-dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation.
Abbasov E; Metzner B; Müller TH; Casper J; Kimmich C; Petershofen EK; Renzelmann A; Rosien B; Thole R; Voß A; Köhne CH
Eur J Haematol; 2022 Sep; 109(3):298-304. PubMed ID: 35687019
[TBL] [Abstract][Full Text] [Related]
17. Addition of doxycycline to ciprofloxacin for infection prophylaxis during autologous stem cell transplants for multiple myeloma.
Sivik JM; Davidson J; Hale CM; Drabick JJ; Talamo G
Support Care Cancer; 2018 Sep; 26(9):3055-3061. PubMed ID: 29564621
[TBL] [Abstract][Full Text] [Related]
18. Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients.
Guimarães T; Borges IC; Spadão FS; Mariano L; Nascimento MM; Higashino H; Rossi F; Rocha V; Costa SF
Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36140048
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.
Yeshurun M; Vaxman I; Shargian L; Yahav D; Bishara J; Pasvolsky O; Wolach O; Lahav M; Gurion R; Magen H; Vidal L; Herscovici C; Peck A; Moshe M; Sela-Navon M; Naparstek E; Raanani P; Rozovski U
Clin Microbiol Infect; 2018 Jul; 24(7):749-754. PubMed ID: 29208561
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
